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endovascular aortic aneurysm repair using modular devices
Ali F. AbuRahma, John E. Campbell, Albeir Y. Mousa, Stephen M. Hass,
Patrick A. Stone, Akhilesh Jain, Aravinda Nanjundappa, L. Scott Dean,
Tammi Keiffer, Joseph Habib
Background: Endovascular aneurysm repair (EVAR) is not generally recom-
mended for patients with hostile neck anatomy. This study analyzed the clin-
ical implications of various clinical features of proximal aortic neck
anatomy.
Methods: Prospectively collected data from 258 EVAR patients using
modular devices were analyzed. Patients were classified as having favorable
neck anatomy (FNA) or hostile neck anatomy (HNA). HNA was defined as any
or all of length of <10 mm, angle of >60, diameter of >28 mm, 50%
circumferential thrombus, 50% calcified neck, and reverse taper. Univar-
iate, multivariate, and Kaplan-Meier analyses were used to compare early
and late clinical outcomes.
Results: FNA was present in 37% and HNA was present in 63%. Clinical and
demographic characteristics were comparable. Technical success was 99%.
Mean follow-up was 22 months (range, 1-78 months). Perioperative compli-
cation rates were 3% for FNA vs 16% for HNA (P = .0027). Perioperative deaths
were 0% for FNA and 3% for HNA (P = .2997). Proximal type I early endoleaks
(intraoperative) occurred in 9% of FNA vs 22% for HNA (P = .0202). Intraoper-
ative proximal aortic cuffs were used to seal endoleaks in 9% of FNA vs 22% of
HNA (P = .0093). At late follow-up, abdominal aortic aneurysm expansion
was noted in 6% of FNA vs 7% of HNA (P = .8509). Rates of freedom from
late type I endoleaks at 1, 2, 3, and 4 years were 97%, 97%, 97%, and 90%
for FNA vs 89%, 89%, 89%, and 89% for HNA (P = .1224); rates for late inter-
ventions were 95%, 90%, 90%, and 90% for FNA vs 95%, 93%, 91%, and 85% for
HNA (P = .6902). Graft patency at 1, 2, and 3 years was 99%, 99%, and 99% for
FNA vs 97%, 92%, and 90% for HNA (P = .0925). The survival rates were 93%,
84%, 76%, and 76% for FNA vs 88%, 82%, 74%, and 66% for HNA (P = .2631).
Reverse taper was a significant predictor for early type I endoleak (odds ratio
[OR], 5.25, P < .0001), reverse taper (OR, 5.95; P < .0001) and neck length
(OR, 4.15; P = .0146) were for aortic cuff use; circumferential thrombus (OR,
2.44; P = .0448), and neck angle (OR, 3.38; P = .009) were for perioperative
complications.
Conclusions: Patients with HNA can be treated with EVAR, but with higher
rates of early (intraoperative) type I endoleak and intervention. The
midterm outcomes are similar to FNA.Late open conversion and explantation of abdominal aortic stent grafts
Clayton J. Brinster, Ronald M. Fairman, Edward Y. Woo, Grace J. Wang,
Jerffrey P. Carpenter, Benjamin M. Jackson
Objectives: To evaluate indications for, operative strategy during, and
outcomes following late open surgical conversion following endovascular
aneurysm repair (EVAR).* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(11)00338-8Methods: Between 2002 and 2009, patients undergoing open abdominal
aortic aneurysm repair at a university hospital were entered prospectively
into a database which was examined to identify patients undergoing open
conversion >30 days after EVAR.
Results: Over 7 years, 21 patients required late open conversion of EVAR.
The average patient age was 75 years (range, 59-88), and there were 16
male (76%) patients. The mean interval to conversion was 33.4 months
(range, 2-73). Eight patients (38%) presented with proximal type I endoleak;
4 patients (19%) presented with type II endoleak and aneurysm expansion; 5
patients (24%) presented with graft migration and aneurysm expansion; and
5 patients (24%) presented with de novo visceral aneurysms. Rupture (1) and
infection (1) were also observed. There were five (24%) emergent cases.
Most patients (12/21, 57%) had more than one reason for conversion. There
were no perioperative deaths; three patients (14%) had major complica-
tions. Grafts requiring conversion were AneuRx (6; Medtronic AVE, Santa
Rosa, Calif), Zenith (6; Cook Inc, Bloomington, Ind), Talent (3; Medtronic),
Excluder (2; W. L. Gore, Flagstaff, Ariz), Anaconda (1; TERUMO Corp, Ann
Arbor, Mich), Ancure (1; Guidant, Menlo Park, Calif), Quantum LP (1; Cordis
Corp, Miami Lakes, Fla), and Powerlink (1; Endologix, Irvine, Calif). The
surgical approach was retroperitoneal in 16 (76%) and transperitoneal in
four (19%) patients. Initial proximal aortic control was supraceliac (9/21),
suprarenal (7/21), or infrarenal (5/21), with stepwise distal clamping to
reduce ischemic time. Complete endograft removal was performed in 17/
21 patients; in 4/21 the distal anastomosis was performed to the endograft
after proximal segment explantation. Reconstruction was completed with
tube (19/21) or aortoiliac (2/21) grafts; in one case, homograft was used.
Mean intraoperative blood loss was 1.9 L (range, 0.4-6.5 L), mean intensive
care unit (ICU) stay was 3 days (range, 2-6), and the mean hospital stay was
10 days (range, 4-39).
Conclusions: While technically challenging, delayed open conversion of
EVAR can be accomplished with low morbidity and mortality in both the
elective and emergent settings. These results reinforce the justification
for long-term surveillance of endografts following EVAR.Graft infection after endovascular abdominal aortic aneurysm repair
Adriana Laser, Nichole Baker, John Rectenwald, Jon L. Eliason, Enrique
Criado-Pallares, Gilbert R. Upchurch Jr
Introduction: Although the natural history and management of infected open
abdominal aortic aneurysm (AAA) repair is well described, only sporadic case
reports have described the fate of patients with infected endografts placed
in the abdominal aorta. The present study describes a tertiary referral center’s
experience with infected endovascular aneurysm repairs (EVARs).
Methods: The medical records of 1302 open and endovascular aortic proce-
dures were queried from January 2000 to January 2010. The cases were
reviewed for prior aortic procedures, prosthetic implants, and etiology of
current open procedure. Demographics, operative details, and perioperative
courses were documented.
Results: Nine patients (1 woman) with a mean age of 71 years had an EVAR
that later required an open procedure for explantation and surgical revision
for suspected infection. All grafts were explanted through a midline transper-
itoneal approach, with a mean time to explant of 33 months. The explanted
130 Abstractsendografts included 4 Zenith (Cook, Bloomington, Ind), 2 Ancure (Endovascu-
lar Technologies, Menlo Park, Calif), 2 Excluders (Gore, Flagstaff, Ariz), and 1
AneuRx (Medtronic, Minneapolis, Minn). Eight of the nine original EVARs were
performed at other hospitals; 1 patient had EVAR and open explant at the
University of Michigan. All patients had preoperative computed tomography
scans, except one who was transferred in extremis with a gastrointestinal
hemorrhage. Three patients also had a tagged leukocyte scan, and two had
magnetic resonance imaging to further reinforce the suspicion of infection
before explantation and bypass planning. Rifampin-soaked Hemashield
(Boston Scientific) in situ grafts were used in four patients, with extra-
anatomic (axillary-bifemoral) bypass used in the other five. The in situ group
had no positive preoperative or postoperative cultures, with the exception of
the unstable patient who died the day of surgery. For the other five patients,
positive tissue cultures were found for Bacteroides, Escherichia coli, coagu-
lase-negative Staphylococcus, Streptococcus, and Candida. Three patients
were found to have aortic-enteric fistula, two of whom died before discharge
from the hospital. The remaining seven survived to discharge. Average length
of stay was 22 days, with a median follow-up of 11 months.
Conclusion: This series of infected EVARs is the largest group of infected AAA
endografts reported to date. Because EVAR of AAAs is presently the most
common method of repair, development of endograft infection, while
rare, can be managed with acceptable mortality rates. Patients presenting
with aortic-enteric fistula after EVAR appear to have a more virulent course.Society for Vascular Surgery Vascular Registry evaluation of stent cell
design on carotid artery stenting outcomes
Jeffrey Jim, Brian G. Rubin, Gregg S. Landis, Christopher T. Kenwood,
Flora S. Siami, Gregorio A. Sicard, SVS Outcomes Committee
Objective: The Society for Vascular Surgery (SVS) Vascular Registry (VR)
collects data on outcomes of carotid endarterectomy and carotid artery stent-
ing (CAS). The purpose of this study was to evaluate the impact of open vs
closed cell stent design on the in-hospital and 30-day outcome of CAS.
Methods: The VR collects provider-reported data on patients using a
Web-based database. Data were analyzed both in-hospital and at 30 days
postprocedure. The primary outcome is combined death/stroke/myocardial
infarction (MI).
Results: As of October 14, 2009, there were 4337 CAS with discharge data and
2397 with 30-day data. Open cell stents (OPEN) were used in 3451 patients
(79.6%), and closed cell stents (CLOSED) were used in 866 patients (20.4%).
Baseline demographics showed no differences in age, gender, race, and
ethnicity. However, the OPEN group had more patients with atherosclerosis
(74.5% vs 67.4%; P = .0003) as the etiology of carotid artery disease. The OPEN
group also had a higher prevalence of preprocedural stroke (25.8% vs 21.4%; P
= .0079), chronic obstructive pulmonary disease (COPD; 21.0% vs 17.6%; P =
.0277), cardiac arrhythmia (14.7% vs 11.4%; P = .0108), valvular heart disease
(7.4% vs 3.7%; P < .0001), peripheral vascular disease (PVD; 40.0% vs 35.3%; P
= .0109), and smoking history (59.0% vs 54.1%; P = .0085). There are no statisti-
cally significant differences in the in-hospital or 30-day outcomes between the
OPENandCLOSEDpatients. Further subgroupanalysesdemonstratedsymptom-
atic patients had a higher event rate than the asymptomatic cohort in both the
OPEN andCLOSED groups. Among symptomatic patients, theOPEN patients had
a lower (0.43% vs 1.41%; P = .0349) rate of in-hospital mortality with no differ-
ence in stroke or transient ischemic attack (TIA). There were no differences in
30-day event rates. In asymptomatic patients, there were also no statistically
significant differences between theOPEN andCLOSED groups. After risk adjust-
ment, there remained no statistically significant differences between groups of
the primary endpoint (death/stroke/MI) during in-hospital or 30 days.
Conclusion: In-hospital and 30-day outcomes after CAS were not signifi-
cantly influenced by stent cell design. Symptomatic patients had higher
adverse event rates compared to the asymptomatic cohort. As there is no
current evidence of differential outcome between the use of open and
closed cell stents, physicians should continue to use approved stent plat-
forms based on criteria other than stent cell design.In-hospital and 30-day outcomes after tibioperoneal interventions in the
US Medicare population with critical limb ischemia
Todd R. Vogel, Viktor Y. Dombrovskiy, Jeffrey L. Carson, Alan M. Graham
Objectives: Catheter-based revascularization has emerged as an alternative
to surgical bypass for the tibioperoneal vessels. The purpose of this analysiswas to describe the outcomes of tibial angioplasty interventions for critical
limb ischemia (CLI) in the hospitalized Medicare population, to examine in-
hospital complications, to define the 30-day readmission and mortality
rates, and to assess secondary procedures performed in this population.
Methods: In-patients with CLI undergoing tibioperoneal angioplasty were
identified using The Centers for Medicare & Medicaid Services in-patient
claims for 2005 to 2007. In-hospital complications, mortality, 30-day secondary
procedures, and 30-day rehospitalization after discharge were described.
Results: A total of 13,258 in-patients underwent tibioperoneal angioplasty
(54.2% men; 75.7% white, 17.1% African American; 42.8% gangrene, 46.7%
rest pain, 10.5% claudication) and 29.3% had a stent, 47.3% had femoral-
popliteal angioplasty, and 20.1% had atherectomy during their initial proce-
dure. Initial hospital complications included renal complications (8.1%),
respiratory complications and pneumonia (5.1%), and cardiac complications
with acute myocardial infarction (3.2%). Mortality in-hospital was 2.8% and
at 30 days was 6.7%. Thirty-day rehospitalization rate was 29.6%. Thirty-
day reinterventions included repeat angiogram (8.5%), repeat tibioperoneal
angioplasty (3.2%), open bypass (2.1%), and lower extremity amputations
(23.8%). Gangrene was the most frequent diagnosis at rehospitalization
(13.5%). Patients with gangrene as an indication for tibioperoneal angioplasty
were 1.8 times (95% confidence interval [CI], 1.56-2.10) as likely as patients
with rest pain to be rehospitalized during 30 days after discharge. Among
comorbidities, predictors of 30-day rehospitalization included chronic renal
failure (odds ratio [OR], 1.4; 95% CI, 1.27-1.52), chronic pulmonary disease
(OR, 1.1; 95% CI, 1.01-1.25), and congestive heart failure (CHF; OR, 1.1;
95% CI, 1.01-1.22). About one-quarter of patients (23.8%) within 30 days after
their initial procedure underwent amputation at any level of the lower limb.
Conclusion: Tibioperoneal angioplasty is associated with frequent in-hospital
complications, an overall 30-day amputation rate of 23.8% for all procedures
and indications, and a 30-day rehospitalization rate of almost 30%. Further
detailed analysis of tibioperoneal intervention is essential to define best
treatment strategies and to minimize complications and readmission rates.
The effect of alcohol on atherosclerotic plaque composition and
cardiovascular events in patients with arterial occlusive disease
Suzanne S. Gisbertz, Wouter J.M. Derksen, Dominique P.V. de Kleijn,
Aryan Vink, Michiel L. Bots, Jean-Paul P.M. de Vries, Frans L. Moll, Gerard
Pasterkamp
Objectives: This study examined the association between alcohol use, the
occurrence of cardiovascular events, and plaque phenotype in patients after
femoral or carotid endarterectomy for arterial occlusive disease. Alcohol has
been shown to have cardiovascular protective effects in patients with
cardiovascular disease as well as in healthy individuals. Whether alcohol
consumption induces changes in atherosclerotic plaque composition has
not been investigated.
Methods: Consecutive femoral (n = 224) and carotid (n = 693) endarterec-
tomy specimens underwent histologic examination for the presence of
collagen, calcifications, smooth muscle cells, macrophages, fat, and intra-
plaque thrombus. Patients were monitored for 3 years after the initial oper-
ation and investigated for the occurrence of cardiovascular events. Primary
outcome was the composite end point “major cardiovascular event.” Alcohol
consumption was categorized as no alcohol use, 1 to 10 U/wk, or >10 U/wk.
Results: The Kaplan-Meier estimate of the major cardiovascular event rate
after 3 years of follow-up in the femoral group was 35% for no alcohol use
and 21% for 1 to 10 U/wk, whereas only 10% of the group >10 U/wk sustained
a major cardiovascular event (P = .010). The plaques of alcohol consumers in
the femoral group contained significantly smaller lipid cores and less macro-
phage infiltration than in abstainers. In the carotid group, the major cardio-
vascular event rate was similar in all three groups, and in addition, no
difference in plaque composition was observed.
Conclusions: This study shows an inverse relationship between alcohol use
and major cardiovascular events after endarterectomy for lower extremity
arterial occlusive disease, accompanied by a more stable plaque phenotype.
However, no such relationship could be observed for patients with cerebro-
vascular disease.Stenting of chronically obstructed inferior vena cava filters
Peter Negle´n, Mathew Oglesbee, Jake Olivier, Seshadri Raju
Objectives: A protective inferior vena cava (IVC) filter may later be incorpo-
rated into a chronic postthrombotic ilio-caval obstruction (occlusive,
Abstracts 131requiring recanalization, or nonocclusive). This study aims to assess the
safety and stent-related outcome following stenting across an obstructed
filter.
Methods: From 1997 to 2009, 708 limbs had stenting for postthrombotic ilio-
caval outflow obstruction (occlusion in 121 limbs). In 25 patients, an IVC
filter was obstructed (Group X). The site was crossed by a guidewire and
balloon dilated. The filter was markedly displaced sidewise or remodeled.
A stent was placed across the IVC filter and redilated. In 28 other patients,
the cephalad stenting terminated below a patent IVC filter (Group B). The
remaining 655 patients had no previous IVC filter placement (Group no IVC
filter present [NF]). The patients were followed to assess patency. The types
of reintervention were noted.
Results: The stenting maneuver through a variety of previously inserted IVC
filters was safely performed without an apparent tear of the IVC, no clinical
bleeding or abdominal symptoms, or pulmonary embolism. Mortality was nil;
morbidity minimal. The primary and secondary cumulative patency rates at
54 months for limbs with postthrombotic obstruction were with and without
IVC filter (38% and 40%; P = .1701 and 79% and 86%; P = .1947, respectively),
and for limbs with stenting across the filter (Group X) and stent termination
below the filter (Group B; 32% and 42%; P = .3064 and 75% and 84%; P = .2788,
respectively), not statistically different. When Group X alone was compared
with Group NF, the secondary patency rate was, however, significantly lower
(75% vs 86%; P = .0453), suggesting that crossing of the stent was associated
with reduced patency. Occlusive postthrombotic disease requiring recanali-
zation was more frequent in Group X than in Group B and Group NF (68%,
25%, and 15%, respectively; P = .004). A comparison was therefore per-
formed only between limbs stented for recanalized occlusions with (n =
23) and without IVC filters (n = 92) showing no difference (cumulative
primary and secondary patency rates 30% and 35%; P = .9678 and 71% and
73%; P = .9319, respectively). Multiple logistic regression analysis also sup-
ported a significant association between patency rate and occlusive disease
(odds ratio, 6.9; 95% confidence interval, 3.4-13.9; P < .0001), but not
between patency rate and presence of an IVC filter (P = .5552).
Conclusions: Stenting across an obstructed IVC filter is safe. It appears
that patency is not influenced by the fact that an IVC filter is crossed
by a stent, but is related to the severity of postthrombotic disease
(occlusive or nonocclusive obstruction) and the associated recanaliza-
tion procedure.Treatment strategies of arterial steal after arteriovenous access
NavYash Gupta, Theodore H. Yuo, Gerhardt Konig IV, Ellen Dillavou, Steven
A. Leers, Rabih A. Chaer, Jae S. Cho, Michel S. Makaroun
Introduction: Ischemic steal syndrome (ISS) associated with arteriovenous
(AV) access is rare but can result in severe complications. Multiple techniques
have been described to treat ISS with varying degrees of success. This study
compares the management and success associated with these techniques.
Methods: Patients with ISS between June 2003 and June of 2008 at the
University of Pittsburgh Medical Center were retrospectively reviewed.
Demographics, type of AV access, management technique, and success of
intervention were recorded. Success was defined as resolution of ISS symp-
toms while preserving access function. One hundred consecutive AV access
procedures were reviewed for comparison. Data were analyzed using c2
test, Fisher’s exact test, and Student’s t test. The study was approved by
our institutional review board.
Results: A total of 114 patients with ISS had amean age of 65 years (range, 20-
90years),werepredominantly female (66%),diabetic (61%),andwithabrachial
origin fistula (69%). Risk factors for ISS included coronary artery disease (CAD; P
< .001), hypertension (P < .001), and tobacco use (P = .048). Women were
noted to have a brachial origin access more frequently than men (odds ratio
[OR], 3.1; P = .009). Forty-four patients withmild stealwere observed. Seventy
patients underwent 87 procedures. Procedures performed included ligation (n
= 27), banding (n = 22), distal revascularization and interval ligation (DRIL; n =
21), improvement of proximal inflow(n= 9), revision usingdistal inflow(RUDI; n
= 4), and proximalization of arterial inflow (PAI; n = 3). Early procedures (<30
days from the index fistula) were mostly ligation (50%) or banding (38%), while
DRIL was the most frequent choice for late interventions (41%). Banding had
a high failure rate (62%) and was the most common reason for reintervention
(8 of 11, 73%) and DRIL had a better success rate than banding (P  .05).
In our current practice, 18% of patients had an AV fistula with the
proximal radial artery (PRA) as the inflow source, while this type of fistula
accounted for only 2% of all ISS patients. Ligation resolved symptoms in all
patients, but the AV access was lost.
Conclusions: Risk factors for development of ISS include CAD, diabetes,
female gender, hypertension, and tobacco use. Among various options to treat
ISS, banding has a low success rate and high likelihood for reintervention,
while DRIL is particularly effective although not uniformly. Less invasive treat-
ment options such as RUDI and PAImay be quite effective in treating ISS. Use of
the PRA as the inflow source may decrease the incidence of ISS.
